Delivery Order SPE2DB22D1041-SPE2DB25FUBZ6
- Not listed
- The Defense Logistics Agency awarded a $1,476.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG inhalers (10.7GM) on September 4, 2025, with an ultimate completion date of September 5, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The performance location is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,696.72 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical products. This firm fixed-price, non-set-aside delivery order was awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $3,734.64 delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 mcg inhalator (10.7gm) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded contract with firm fixed pricing carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $7,652.36 delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM, a pharmaceutical product supporting federal medical supply needs. This non-set-aside, competitively awarded contract reflects a firm fixed price delivery order with an ultimate completion date of September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,176.00 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical products. This competitively awarded, firm fixed-price contract was executed on August 28, 2025, with an ultimate completion date of August 29, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $18,115.50 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 mcg inhaler (10.7 gm) on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed price contract represents a competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $2,560.18 firm fixed price delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG inhaler 10.7GM, with an ultimate completion date of August 6, 2025. This non-set-aside contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from the contractor's corporate office...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,328.03 firm fixed price delivery order for AIRSUPRA 90-80 MCG Inhaler 10.7GM on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside competitive contract will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,828.45 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical products. The contract is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, and was awarded on July 18, 2025. No set-aside designation was used in this competitive award. Performance will take place in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a $5,376.82 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for AIRSUPRA 90-80 MCG Inhaler in 10.7GM units, with completion scheduled for August 18, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUBZ6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $16,762.09 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical supplies. This firm fixed price, non-set-aside contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as part of its extensive portfolio serving military and veteran healthcare systems. This delivery order operates under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The contract serves various government customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.8k | 9/11/25 |